ASHPOfficial

Therapeutic Thursdays (C.E.): Opioid De-escalation: Are We Exceeding the Speed Limit?

July 30, 2022

Overprescribing of opioids led to the development of the CDC guidelines for chronic pain which recommended opioid taper in patients when risk outweighed benefit, especially in patients receiving high dose opioids, in order to decrease risk of opioid-related adverse reactions and overdose potential.  However, increased risk of harm has been reported in those who may have had opioids tapered inappropriately.  This podcast will highlight the process for opioid tapering based on length of opioid therapy and potential harm from opioid use.  

The information presented during the podcast reflects solely the opinions of the presenter. The information and materials are not, and are not intended as, a comprehensive source of drug information on this topic. The contents of the podcast have not been reviewed by ASHP, and should neither be interpreted as the official policies of ASHP, nor an endorsement of any product(s), nor should they be considered as a substitute for the professional judgment of the pharmacist or physician.